Cancer/ Clinical/ News EU regulators back blood cancer stem cell therapy Richard Staines advanced therapy, cancer, CHMP, ema, Oncology, stem cell 0 Comment Molmed’s treatment aims to prevent reduce risk of graft-versus-host disease. Share X EU regulators back blood cancer stem cell therapy https://pharmaphorum.com/news/eu-regulators-back-blood-cancer-stem-cell-therapy/